PRME

Prime Medicine (PRME)

About Prime Medicine (PRME)

Prime Medicine, Inc. is a biotechnology company, which engages in developing one-time curative genetic therapies. The company was founded by David R. Liu on September 13, 2019 and is headquartered in Cambridge, MA.

Details

Daily high
$3.59
Daily low
$3.30
Price at open
$3.36
52 Week High
$6.94
52 Week Low
$1.11
Market cap
584.9M
Dividend yield
0.00%
Volume
3.6M
Avg. volume
3.3M
P/E ratio
-2.20

Prime Medicine News

Details

Daily high
$3.59
Daily low
$3.30
Price at open
$3.36
52 Week High
$6.94
52 Week Low
$1.11
Market cap
584.9M
Dividend yield
0.00%
Volume
3.6M
Avg. volume
3.3M
P/E ratio
-2.20